Daily non-political popular news in brief.
Transparent zebrafish help researchers track breast cancer
10-22-2007 · EurekAlert!What if doctors could peer through a patient's skin and see a cancer tumor growing? They'd be able to study how tumor cells migrate: how they look, how they interact with the blood system to find nourishment to grow and spread through the body. Scientists at the UCSD School of Medicine can't look through human skin. But a small, tropical minnow fish common to aquariums has given researchers a window for viewing live, human cancer cells in action.
Read more »
Keywords: transparent, zebrafish, researchers, track, breast, cancer, researcher
« Previous | Next »
Similar news on "Transparent zebrafish help researchers track breast cancer":
- Vet medicine researcher examines link between cancer, Down syndrome
02-04-2008 · EurekAlert!
There's new hope for breast cancer research, and it's coming from a very unlikely place. Researchers at the Texas A&M University College of Veterinary Medicine & Biomedical Sciences recently published articles in the journals Molecular and Cellular Biology and Carcinogenesis indicating that a protein long suspected to play a role in Down Syndrome may also contribute to treating this devastating disease.
Similar news · Read more »
- Blocking cancer-causing gene improves radiation effectiveness, Jefferson researchers find
11-08-2006 · EurekAlert!
Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists has found. Using a combination of zebrafish and antisense technology, they've shown that the drug flavopiridol works by blocking the activity of a gene, cyclin D1, which is overexpressed in about half of all breast cancers. Similar techniques in the future, the scientists say, may enable researchers to better gauge the effects of drugs.
Similar news · Read more »
- PET scans track small tumors after stereotactic body radiotherapy
10-28-2007 · EurekAlert!
Readily available CT screening for lung cancer is increasing the discovery of small, primary lung cancers. For many, a radiation technique called stereotactic body radiotherapy presents a less invasive treatment option to surgery that is typically offered to nonsurgical candidates. In a study presented today researchers present data showing metabolic response monitored by FDG PET may be an early surrogate for local treatment failure which may allow timely salvage surgery if deemed necessary.
Similar news · Read more »
- Peptide vaccine fights off breast tumors with aid of bacteria-mimicking agents
02-01-2007 · EurekAlert!
With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice. The strategy, they say, holds promise for the future use of peptide vaccines in women who are at high risk for developing breast cancer.
Similar news · Read more »
- Study suggests newer breast cancer drug may protect heart
06-08-2007 · EurekAlert!
By uncovering how one breast cancer drug protects the heart and another does not, Duke University Medical Center researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
Similar news · Read more »
- Src inhibitors may prove beneficial in breast cancer therapy
07-12-2007 · EurekAlert!
Estrogen, which binds estrogen receptor alpha (ER-alpha), is a risk factor for breast cancer development. However, one-third of new breast cancers lack detectable ER-alpha. These ER-alpha-negative cancers are more aggressive and have a worse prognosis than do ER-alpha-positive breast cancers, and have been thought to be estrogen independent. In a new JCI study, University of Miami researchers shed further light on the mechanisms regulating ER-alpha expression levels during breast cancer.
Similar news · Read more »
- Gold nanoparticles may pan out as tool for cancer diagnosis
07-31-2007 · EurekAlert!
When it comes to searching out cancer cells, gold may turn out to be a precious metal. Purdue University researchers have created gold nanoparticles capable of identifying marker proteins making the tiny particles a potential tool to better diagnose and treat breast cancer.
Similar news · Read more »
- Jefferson researchers uncover new evidence of prolactin's possible role in breast cancer
09-28-2007 · EurekAlert!
Scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered new molecular evidence of the role of the hormone prolactin in breast cancer. They have found that prolactin, a pituitary hormone that normally stimulates breast development and milk production, initiates a new "signaling pathway" that may regulate the growth and survival of breast cancer cells.
Similar news · Read more »
- Analysis of breast and colon cancer genes finds many areas of differences between tumors
10-11-2007 · EurekAlert!
Researchers from University Hospitals Ireland Cancer Center and Case Western Reserve University School of Medicine are part of a new national study that has analyzed more than 18,000 genes, including 5,000 previously unmapped genes, from breast and colorectal tumors. The study shows a great number of genetic differences between breast and colon cancer tumors, leading the researchers to conclude that new drugs must be developed that can hit these newly identified genetic targets in a manner specific to each different individual's tumor.
Similar news · Read more »
- Researchers identify unusual molecular switch for common form of advanced breast cancer
11-08-2007 · EurekAlert!
New evidence demonstrates that a novel molecular switch is involved in the development of a common form of advanced breast cancer, known as locally advanced breast cancer. The research, published by Cell Press in the Nov. 9, 2007 issue of Molecular Cell, provides an exciting paradigm shift in the understanding of a key event in breast cancer development and presents new therapeutic opportunities for this deadly disease.
Similar news · Read more »
